Search research articles
Contact Us
Filters
Showing results (141-150 of 225) with videos related to
Page
of 23
Sort By:
Journal of Alzheimer'S Disease : JAD
|
February 27, 2018
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia
Grazia D'Onofrio, Francesco Panza, Daniele Sancarlo, et al.
Journal of Neurochemistry
|
September 17, 2021
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment
Giovanni Zuliani, Alessandro Trentini, Gloria Brombo, et al.
Journal of Alzheimer'S Disease : JAD
|
July 5, 2008
The RELN locus in Alzheimer's disease
Davide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Chronobiology International
|
July 15, 2017
Analysis of MTNR1B gene polymorphisms in relationship with IRS2 gene variants, epicardial fat thickness, glucose homeostasis and cognitive performance in the elderly
Gianluigi Mazzoccoli, Mariangela Pia Dagostino, Giulia Paroni, et al.
Age (Dordrecht, Netherlands)
|
July 20, 2010
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients
Maria G Matera, Daniele Sancarlo, Francesco Panza, et al.
Pharmacogenetics and Genomics
|
September 23, 2010
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease
Davide Seripa, Alessandra Bizzarro, Andrea Pilotto, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 11, 2016
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Madia Lozupone, Francesco Panza, Eleonora Stella, et al.
Annals of Neurology
|
January 27, 2006
Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia
Adele Acciarri, Carlo Masullo, Alessandra Bizzarro, et al.
Expert Review of Neurotherapeutics
|
October 3, 2018
BACE inhibitors in clinical development for the treatment of Alzheimer's disease
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Expert Opinion on Pharmacotherapy
|
April 20, 2019
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
Giancarlo Logroscino, Bruno P Imbimbo, Madia Lozupone, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 225) with videos related to
Sort By:
Page
of 23
Journal of Alzheimer'S Disease : JAD
|
February 27, 2018
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia
Grazia D'Onofrio, Francesco Panza, Daniele Sancarlo, et al.
Journal of Neurochemistry
|
September 17, 2021
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment
Giovanni Zuliani, Alessandro Trentini, Gloria Brombo, et al.
Journal of Alzheimer'S Disease : JAD
|
July 5, 2008
The RELN locus in Alzheimer's disease
Davide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Chronobiology International
|
July 15, 2017
Analysis of MTNR1B gene polymorphisms in relationship with IRS2 gene variants, epicardial fat thickness, glucose homeostasis and cognitive performance in the elderly
Gianluigi Mazzoccoli, Mariangela Pia Dagostino, Giulia Paroni, et al.
Age (Dordrecht, Netherlands)
|
July 20, 2010
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients
Maria G Matera, Daniele Sancarlo, Francesco Panza, et al.
Pharmacogenetics and Genomics
|
September 23, 2010
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease
Davide Seripa, Alessandra Bizzarro, Andrea Pilotto, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 11, 2016
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Madia Lozupone, Francesco Panza, Eleonora Stella, et al.
Annals of Neurology
|
January 27, 2006
Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia
Adele Acciarri, Carlo Masullo, Alessandra Bizzarro, et al.
Expert Review of Neurotherapeutics
|
October 3, 2018
BACE inhibitors in clinical development for the treatment of Alzheimer's disease
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Expert Opinion on Pharmacotherapy
|
April 20, 2019
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
Giancarlo Logroscino, Bruno P Imbimbo, Madia Lozupone, et al.
Page
of 23